A Phase II Study of Maribavir to Treat Resistant Cytomegalovirus Infection in Transplant Recipients
[Protocol 12-281] |
Papanicolaou, Genovefa |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
|
A Phase III Study of Accelerated Whole Breast Radiation Therapy with a Boost versus Standard Whole Breast Radiation with a Boost in Women with Early-Stage Breast Cancer (RTOG 1005)
[Protocol 12-158] |
Parhar, Preeti |
|
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048] |
Park, Jae |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040] |
Park, Jae |
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
[Protocol 12-200] |
Park, Jae |
|
A Phase I/II Study of Low-Dose Cytarabine and Lintuzumab-Ac-225 in Older Patients with Previously Untreated Acute Myeloid Leukemia
[Protocol 09-053] |
Park, Jae |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123] |
Pentsova, Elena |
|
A Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia
[Protocol 11-024] |
Perales, Miguel-Angel |
- Blood and Marrow Transplantation
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma
[Protocol 07-147] |
Perales, Miguel-Angel |
- Blood & Marrow Stem Cell Transplantation
- Sibling and Unrelated Volunteer
- Lymphoma
|
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer
[Protocol 11-206] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114] |
Powell, Simon |
|
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198] |
Pratilas, Christine |
|
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD
[Protocol 09-072] |
Prockop, Susan |
- Blood and Marrow Transplantation
|
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
[Protocol 07-098] |
Pusic, Andrea |
- Head & Neck Cancer
- Survivorship
|
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
[Protocol 07-150] |
Pusic, Andrea |
|
Quality of Life and Patient-Reported Outcomes After Breast Reconstruction Surgery
[Protocol 12-093] |
Pusic, Andrea |
- Breast Cancer
- Survivorship
|
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
[Protocol 05-058] |
Pusic, Andrea |
- Breast Cancer
- Survivorship
|
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076] |
Rampal, Raajit |
- Hematology
- Hematologic Disorders
- Hematologic Malignancies
- Leukemia
- Myeloproliferative Neoplasm
|
